Table 2.
Mouse | Strain | Sex | Liver weight to body weight ratio (%) | hapoA-II (g/L) | Amyloidosis index | LS (kPa) | Success rate for LSM (%) |
1 | Y | F | 5.1 | 0.19 | 0 | 3.9 | 90 |
2 | Y | M | ND | ND | 0 | 9.3 | 83 |
3 | Y | F | ND | ND | 0 | 5.9 | 100 |
4 | Y | F | 4.4 | 0.22 | 0 | 4.1 | 100 |
5 | Y | F | 4.5 | 0.22 | 0 | 4.1 | 100 |
6 | Y | F | 4.6 | ND | 0 | 4.7 | 86 |
7 | Y | F | ND | ND | 1 | 12.6 | 100 |
8 | Y | M | 5.2 | 0.23 | 0 | 3.9 | 100 |
9 | Y | F | ND | ND | 0 | 11.2 | 92 |
10 | K | M | ND | 0.15 | 1 | 23.7 | 100 |
11 | K | M | 16.0 | 0.55 | 4 | 124.0 | 74 |
12 | K | M | 13.8 | 0.57 | 2 | 124.0 | 57 |
13 | K | F | 15.8 | 0.54 | 4 | 168.8 | 100 |
14 | K | F | 22.8 | 0.80 | 3 | 168.8 | 82 |
15 | K | F | 18.2 | 0.44 | 3 | 168.8 | 100 |
16 | K | F | 12.1 | 0.42 | 2 | 94.9 | 100 |
17 | K | F | 5.0 | 0.28 | 0 | 4.4 | 96 |
18 | F | M | 7.6 | 0.66 | 1 | 50.2 | 100 |
19 | F | M | ND | 0.76 | 1 | 73.0 | 100 |
20 | F | M | ND | 0.44 | 1 | 13.5 | 92 |
21 | F | F | 12.9 | ND | 2 | 124.0 | 95 |
22 | F | M | ND | 0.35 | 2 | 155.5 | 100 |
23 | F | F | 16.3 | 0.58 | 3 | 168.8 | 95 |
24 | F | M | 15.7 | 0.53 | 3 | 168.8 | 69 |
25 | F | M | 14.9 | 0.59 | 3 | 168.8 | 100 |
26 | F | M | 13.7 | 0.64 | 3 | 124.0 | 89 |
27 | F | M | 10.8 | 0.59 | 3 | 168.8 | 100 |
LSM: Liver stiffness measurement; ND: Not determined.